Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells-Reference-Cited by-同舟云学术

Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells

Published:2015-01 Issue:2 Volume:356 Page:846-854
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Hamano Shingo,Mori Yoshinori,Aoyama Mineyoshi,Kataoka Hiromi,Tanaka Mamoru,Ebi Masahide,Kubota Eiji,Mizoshita Tsutomu,Tanida Satoshi,Johnston Randal N.,Asai Kiyofumi,Joh Takashi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Gastric cancer epidemiology and risk factors;Kelley;J. Clin. Epidemiol,2003

2. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J. Clin. Oncol,2006

3. Gastric cancer;Hartgrink;Lancet,2009

4. Is there a role for second-line chemotherapy in advanced gastric cancer?;Wesolowski;Lancet Oncol,2009

5. Biologic and therapeutic role of HER2 in cancer;Menard;Oncogene,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies;Cancers;2023-11-30

2. Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer;Cancer Immunology, Immunotherapy;2023-08-01

3. Modulation of Reoviral Cytolysis (I): Combination Therapeutics;Viruses;2023-06-29

4. Mammalian orthoreovirus infection in human epidermal growth factor receptor 2 positive (HER2+) breast cancer cells;2023-05-10

5. Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer;2022-12-16